Newsletter | September 14, 2011

9.14.11 -- Clinical Trial Outsourcing: Why China?

Clinical Leader
Clinical Trial Outsourcing: Why China?
By Mike Anello, Life Science Leader magazine

Recent trends show that an ever-increasing percentage of clinical trials are being performed offshore. As the pressure increases to reduce the cost of prescription drugs, pharmaceutical manufacturers search for ways to reduce costs in research and production.
Read more.

Featured Articles

Preparing For The Physician's Payment Sunshine Act Of 2009
Over the past several years, interactions between health care providers, health care institutions, and life science companies (pharmaceutical and medical device) have been under increased scrutiny. The push to understand these interactions, and to show where conflicts of interest may exist, has led to several regulatory actions. Read more.

New FDA Guidance On Clinical Monitoring Arrives
The draft guidance for industry, Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring, is early evidence that the findings and recommendations of the Clinical Trials Transformation Initiative (CTTI) are beginning to take hold in practice in the clinical trials domain. Read more.

Turning Compliance Into A Sustainable Business Advantage
The past few years have presented extraordinary regulatory and quality compliance challenges for pharmaceutical, biotechnology, and medical device companies. They are required to do more with less as a result of consolidation, restructuring, and economic uncertainty. Read more.


Join industry leaders from Baxter Healthcare, Boston Scientific, Biomet Orthopedics and many more at the Clinical Trials for Medical Devices Conference, November 17 to 18, 2011 in Chicago, IL. Attending this conference will enable you to discuss the current challenges medical device clinical trials are facing today including CRO selection, patient recruitment and retention, site section, and FDA requirements including the 510(k) processes.

Featured Products

Oncology Clinical Trials And Studies
The ICON Oncology Solution expedites every aspect of a cancer drug trial. It combines global experience in all phases of oncology drug development with expertise in tumor imaging, laboratory IVRS, central data management, electronic data capture, and regulatory oncology issues. Read more.

Biologics: From Molecule To Market
Developing a biologic therapy for market takes a special kind of expertise. With 35 years of experience as a global contract service organization, SGS provides integrated biologic solutions, from preclinical activities to phase I-IV trials, and bioanalytical and quality control testing. Read more.

Top News
Industry Event

Webinar: The Changing Role Of The CRO
September 21, 2011
London 3:00 PM/New York 10:00 AM

This webinar examines how trial sponsors should look at one particular service offering — patient recruitment and retention — to ensure they are being best served by the one-supplier approach. Learn more.